188 related articles for article (PubMed ID: 11760783)
1. Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside.
Truss MC; Stief CG; Uckert S; Becker AJ; Wefer J; Schultheiss D; Jonas U
World J Urol; 2001 Nov; 19(5):344-50. PubMed ID: 11760783
[TBL] [Abstract][Full Text] [Related]
2. Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Forssmann WG; Jonas U
Urol Res; 1996; 24(3):129-34. PubMed ID: 8839479
[TBL] [Abstract][Full Text] [Related]
3. Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder.
Truss MC; Stief CG; Uckert S; Becker AJ; Schultheiss D; Machtens S; Jonas U
World J Urol; 2000 Dec; 18(6):439-43. PubMed ID: 11204266
[TBL] [Abstract][Full Text] [Related]
4. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS.
Andersson KE; Uckert S; Stief C; Hedlund P
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):928-33. PubMed ID: 17806124
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization.
Truss MC; Uckert S; Stief CG; Kuczyk M; Jonas U
Urol Res; 1996; 24(3):123-8. PubMed ID: 8839478
[TBL] [Abstract][Full Text] [Related]
7. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
Montorsi F; Corbin J; Phillips S
J Sex Med; 2004 Nov; 1(3):322-36. PubMed ID: 16422964
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase (PDE) inhibitors in the treatment of lower urinary tract dysfunction.
Uckert S; Oelke M
Br J Clin Pharmacol; 2011 Aug; 72(2):197-204. PubMed ID: 21745238
[TBL] [Abstract][Full Text] [Related]
9. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro.
Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U
Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357
[TBL] [Abstract][Full Text] [Related]
10. STIMULATION OF THE CYCLIC AMP/GMP SIGNALLING ENHANCES THE RELAXATION OF ISOLATED HUMAN DETRUSOR SMOOTH MUSCLE ACHIEVED BY PHOSPHODIESTERASE INHIBITORS.
Rahardjo HE; Ückert S; Maerker V; Bannowsky A; Kuczyk MA; Kedia GT
Georgian Med News; 2021 Apr; (313):7-12. PubMed ID: 34103422
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide metabolism including nitric oxide and phosphodiesterase-related targets in the lower urinary tract.
Uckert S; Kuczyk MA
Handb Exp Pharmacol; 2011; (202):527-42. PubMed ID: 21290241
[TBL] [Abstract][Full Text] [Related]
12. [Bladder and cavernous contractility and relaxation among intracellular messengers, changes in sarcoplasmatic free calcium and phosphodiesterase activity].
Alberti C
Arch Ital Urol Androl; 2000 Jun; 72(2):75-82. PubMed ID: 10953393
[TBL] [Abstract][Full Text] [Related]
13. [Significance of phosphodiesterase isoenzymes in the control of human detrusor smooth muscle function. An immunohistochemical and functional study].
Uckert S; Sigl K; Waldkirch ES; Sandner P; Ulbrich E; Oelke M; Stief CG; Kuczyk MA
Urologe A; 2009 Jul; 48(7):764-9. PubMed ID: 19352616
[TBL] [Abstract][Full Text] [Related]
14. Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.
Uckert S; Stief CG
Handb Exp Pharmacol; 2011; (204):307-22. PubMed ID: 21695646
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle.
Qiu Y; Kraft P; Craig EC; Liu X; Haynes-Johnson D
Urology; 2002 Jan; 59(1):145-9. PubMed ID: 11796312
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitors in clinical urology.
Ückert S; Kuczyk MA; Oelke M
Expert Rev Clin Pharmacol; 2013 May; 6(3):323-32. PubMed ID: 23656343
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase inhibitors for the treatment of erectile dysfunction.
Küthe A; Montorsi F; Andersson KE; Stief CG
Curr Opin Investig Drugs; 2002 Oct; 3(10):1489-95. PubMed ID: 12431025
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase inhibitors in female sexual dysfunction.
Mayer M; Stief CG; Truss MC; Uckert S
World J Urol; 2005 Dec; 23(6):393-7. PubMed ID: 16247643
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle.
Taher A; Meyer M; Stief CG; Jonas U; Forssmann WG
World J Urol; 1997; 15(1):32-5. PubMed ID: 9066092
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study.
Kedia GT; Oelke M; Sonnenberg JE; Sohn M; Bannowsky A; Kuczyk MA; Ückert S
Eur J Pharmacol; 2014 Oct; 741():330-5. PubMed ID: 25160741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
